Editorial2 min read
From Evidence to Better Decisions
New evidence deserves attention. Better care requires interpretation, clinical judgment, and an understanding of the healthcare setting.
Read articleArticle library
Articles
Clinical evidence and practical interpretation - rebuilt for focused reading on any screen.
Evidence Update2 min read
Papers Worth Knowing
Four studies. Four clinically important questions.
Read article
Cover Feature7 min read
Diabetes, Earlier.
Are we protecting organs soon enough? New international evidence. Philippine clinical realities. Decisions that matter from diagnosis.
Read article
Evidence Synthesis5 min read
Septic Shock: Have We Been Giving Too Much Fluid?
Early vasopressors, fluid volumes, and the evidence behind better resuscitation decisions.
Read article
Therapeutic Review4 min read
COPD Beyond Inhalers
Can biologics reach more patients? IL-33 inhibition may extend exacerbation prevention beyond eosinophil-selected trials, but important questions remain.
Read article
Philippine Clinical Focus4 min read
Antibiotic Resistance: The Philippine Reality
What should surveillance change in prescribing?
Read article
Practice Changer3 min read
The Fatty Liver Trap: What Normal Liver Enzymes Can Miss
Why routine liver panels can miss progressive liver disease in patients with metabolic risk.
Read article
Tech Check3 min read
AI in Eye Care: Better Screening—or Simply Fewer Referrals?
AI-assisted diabetic retinal screening is promising. But do abnormal findings lead to completed follow-up and care?
Read article
Clinical Discovery2 min read
Two Studies. Two Clinical Lessons.
Maternal diet and infant food allergy; optogenetics and vision restoration.
Read article
Evidence Update2 pages
ESC 2026 — Five Findings Worth Knowing
New data. Different patients. Practical implications.
Read article
Cover Feature6 pages
Colchicine: Why Do the Trials Disagree?
A Medeasy evidence synthesis and updated clinical perspective.
Read article
Clinical Discovery3 pages
SINGLE-AF: Do We Anticoagulate Too Late?
A randomized trial in an intermediate-risk AF population.
Read article
Therapeutic Review3 pages
Baxdrostat: The Aldosterone Comeback
Where does baxdrostat fit? Key takeaways and clinical pearls.
Read article
Clinical Discovery1 page
Target Engagement Is Not Enough
A closer look at CARDIO-TTRansform.
Read article
Tech Check2 pages
Can an App Really Lower Blood Pressure?
What makes digital health worth using?
Read article
Practice Changer1 page
Monday Morning Medicine
Eight practical lessons to carry into the week ahead.
Read article
Evidence Update1 page
Four Studies. Real Impact.
An evidence snapshot for clinical practice.
Read article
Medeasy Picks1 page
Use Medeasy. Make Everyday Practice More Rewarding.
Rewards without changing the clinical decision.
Read article
Cover Feature7 min read
Medicine, Reimagined
Fifteen developments changing clinical medicine in 2026 - and what deserves a physician's attention now.
Read article
Clinical Discovery6 min read
The Peptide Revolution: Retatrutide
Why triple agonism may represent the next frontier in obesity pharmacotherapy.
Read article
Drug of the Month5 min read
Dapagliflozin Beyond Glycemic Control
A practical view of broad cardiorenal benefits across heart failure and chronic kidney disease.
Read article
Interesting Medicines6 min read
Inclisiran & Evolocumab: Different Paths, Same Goal
Two PCSK9-directed strategies, different mechanisms, and different levels of cardiovascular outcomes evidence.
Read article
Therapeutic Review6 min read
ELEVATE: A Deep Dive
Phase 3 evidence for adjuvant ensartinib after complete resection of ALK-positive NSCLC.
Read article
Clinical Discovery5 min read
Beyond BMI: A More Complete View of Obesity
Move from size alone toward adiposity, fat distribution, function, and health impact.
Read article
Practice Changer7 min read
Stage 1 Hypertension: Treat Early, Treat Smart
A stepwise pathway from accurate diagnosis to risk-based treatment and follow-up.
Read article
Future Medicine5 min read
Lipids Reimagined
Move beyond LDL-C alone toward individualized, risk-based prevention.
Read article
Practice Changer6 min read
Type 2 Diabetes in 2026
Treat the patient - not just the A1C - with an outcomes-first, person-centered pathway.
Read article
Tech Check4 min read
Your Watch Found AF. Now What?
A wearable alert is a starting point - not a diagnosis.
Read article
Tech Check4 min read
How Much Can You Trust Smartwatch Blood Pressure?
Useful for signals and trends; insufficient as the default basis for diagnosis or treatment decisions.
Read article